Calderon, Gilbert, Jr. .
HRN: 24-06-52 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/18/2023
12/25/2023
IVT
60mg
Q24
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes